DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹109 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr |
What is the latest Contingent Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹108 Cr |
| Mar2021 | ₹96 Cr |
How is Contingent Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹109 Cr | 0.00 | |
| Mar2024 | ₹109 Cr | 1.77 | |
| Mar2023 | ₹107 Cr | -0.37 | |
| Mar2022 | ₹108 Cr | 11.62 | |
| Mar2021 | ₹96 Cr | - | |
Compare Contingent Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹101,937.7 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,888.0 Cr | 3.9% | -5.4% | -12.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 2.3% |
-8.1% |
13.5% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses